What will be interesting to see is how the new CEO generates investor interest. We could see a very positive market perception next year at conferences as we get closer to PISCES data mid 2018. This is a very exciting time for Oncosec. Lots of anticipation building up for 2018. Institutions will be watching and hopefully taking positions.